Smd2

In this work, magnesium silicate-based sulfonated polystyrene sphere composites (SPS/MgSi) were synthesized by one-step (SMD1) and two-step (SMD2) methods. For SMD1, MgSi particles were densely assembled on the surface of SPS, assisted by complexation between Fe3+ and hydroxyl phenol. For SMD2, SPS/SiO2 was firstly obtained by the same method as SMD1, and then SPS/SiO2 was transformed directly to SPS/MgSi under hydrothermal conditions. Therefore, MgSi obtained by the two-step method had an interwoven structure. Compared to SPS, MgSi and SMD1, SMD2 presented a larger specific surface area and more negative surface charges. Therefore, SMD2 showed superior adsorption performance toward CIP with concentrations of 5, 10 and 50 mg/L, and for 50 mg/L, the equilibrium adsorption capacity could reach 329.7 mg/g. The adsorption process is fast and can be described by the pseudo-second-order kinetic model. The relationship between pH value and Zeta potential demonstrated that electrostatic interaction dominated the adsorption process. In addition, competitive adsorption showed that the effect of Na+ was negligible but the effect of Ca2+ was dependent on its concentration. Humid acid (HA) could slightly promote the absorption of CIP by SMD2. After five rounds of adsorption-desorption, the equilibrium adsorption capacity of SMD2 still remained at 288.6 mg/L for 50 mg/L CIP. Notably, SMD2 presented likewise superior adsorption capacity for CIP with concentrations of 10 and 50 mg/L in Minjiang source water. All the results indicated that this synthesis method is universal and that SMD2 has potential as an adsorbent for CIP removal from aquatic environments.

The accessory protein MD2 has been implicated in LPS-mediated activation of the innate immune system by functioning as a co-receptor with TLR4 for LPS binding at the cell surface. Epithelial cells that play a role in primary immune response, such as in the lung or gut, often express TLR4, but are dependent on circulating soluble MD2 (sMD2) to bind TLR4 to assemble the functional receptor. In this study, we show that sMD2 incubation with HEK293 epithelial cells transfected with TLR4 increases the cell surface levels of TLR4 in the absence of LPS. Dose response studies reveal that a threshold sMD2 concentration (approximately 450 nM) stimulates maximal TLR4 levels on the cell surface, whereas higher concentrations of sMD2 (approximately 1800 nM) reduce these enhanced TLR4 levels. We show evidence that MD2 multimer formation is increased at these higher concentrations of sMD2 and that addition of LPS to sMD2-stimulated cells masks the enhanced TLR4 cell surface levels, most likely due to the LPS-induced downregulation of TLR4 by endocytosis following receptor stimulation. All together, these results support a model in which sMD2 binds to TLR4 and increases TLR4 levels at the cell surface by preventing TLR4 turnover through the endocytic pathway. Thus, sMD2 may prime epithelial cells for enhanced immunoresponsive function prior to LPS exposure.

The effects of 4-chloro-3-nitro-N-butylbenzenesulfonamide (SMD2) on KV3.1 channels, heterologous expressed in L-929 cells, were studied with the whole cell patch-clamp technique. SMD2 blocks KV3.1 in a reversible and use-dependent manner, with IC50 around 10 µM, and a Hill coefficient around 2. Although the conductance vs. voltage relationship in control condition can be described by a single Boltzmann function, two terms are necessary to describe the data in the presence of SMD2. The activation and deactivation time constants are weakly voltage dependent both for control and in the presence of SMD2. SMD2 does not change the channel selectivity and tail currents show a typical crossover phenomenon. The time course of inactivation has a fast and a slow component, and SMD2 significantly decreased their values. Steady-state inactivation is best described by a Boltzmann equation with V 1/2 (the voltage where the probability to find the channels in the inactivated state is 50%) and K (slope factor) equals to -22.9 ± 1.5 mV and 5.3 ± 0.9 mV for control, and -30.3 ± 1.3 mV and 6 ± 0.8 mV for SMD2, respectively. The action of SMD2 is enhanced by high frequency stimulation, and by the time the channel stays open. Taken together, our results suggest that SMD2 blocks the open conformation of KV3.1. From a pharmacological and therapeutic point of view, N-alkylsulfonamides may constitute a new class of pharmacological modulators of KV3.1.